HUP0103826A2 - Eljárás zofenopril kalciumsó előállítására és a vegyületet tartalmazó gyógyszerkészítmény és alkalmazása - Google Patents
Eljárás zofenopril kalciumsó előállítására és a vegyületet tartalmazó gyógyszerkészítmény és alkalmazásaInfo
- Publication number
- HUP0103826A2 HUP0103826A2 HU0103826A HUP0103826A HUP0103826A2 HU P0103826 A2 HUP0103826 A2 HU P0103826A2 HU 0103826 A HU0103826 A HU 0103826A HU P0103826 A HUP0103826 A HU P0103826A HU P0103826 A2 HUP0103826 A2 HU P0103826A2
- Authority
- HU
- Hungary
- Prior art keywords
- preparation
- calcium salt
- medicament containing
- zofenopril calcium
- zofenopril
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- NSYUKKYYVFVMST-LETVYOFWSA-L zofenopril calcium Chemical class [Ca+2].C([C@@H](C)C(=O)N1[C@@H](C[C@@H](C1)SC=1C=CC=CC=1)C([O-])=O)SC(=O)C1=CC=CC=C1.C([C@@H](C)C(=O)N1[C@@H](C[C@@H](C1)SC=1C=CC=CC=1)C([O-])=O)SC(=O)C1=CC=CC=C1 NSYUKKYYVFVMST-LETVYOFWSA-L 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01F—COMPOUNDS OF THE METALS BERYLLIUM, MAGNESIUM, ALUMINIUM, CALCIUM, STRONTIUM, BARIUM, RADIUM, THORIUM, OR OF THE RARE-EARTH METALS
- C01F11/00—Compounds of calcium, strontium, or barium
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Geology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1998MI001833A IT1301993B1 (it) | 1998-08-04 | 1998-08-04 | Processo per la preparazione di zofenopril sale di calcio. |
| PCT/EP1999/005461 WO2000007984A1 (en) | 1998-08-04 | 1999-07-30 | A process for the preparation of zofenopril calcium salt |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0103826A2 true HUP0103826A2 (hu) | 2002-02-28 |
| HUP0103826A3 HUP0103826A3 (en) | 2002-03-28 |
| HU227557B1 HU227557B1 (en) | 2011-08-29 |
Family
ID=11380611
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0103826A HU227557B1 (en) | 1998-08-04 | 1999-07-30 | A process for the preparation of zofenopril calcium salt and medicament containing it and its use |
Country Status (32)
| Country | Link |
|---|---|
| US (2) | US6521760B1 (hu) |
| EP (1) | EP1102745B1 (hu) |
| JP (1) | JP2002522417A (hu) |
| KR (1) | KR100593428B1 (hu) |
| CN (1) | CN1146538C (hu) |
| AT (1) | ATE266635T1 (hu) |
| AU (1) | AU5372299A (hu) |
| BG (1) | BG65022B1 (hu) |
| BR (1) | BR9912842A (hu) |
| CA (1) | CA2339283C (hu) |
| CU (1) | CU23171A3 (hu) |
| CZ (1) | CZ301908B6 (hu) |
| DE (1) | DE69917282T2 (hu) |
| DK (1) | DK1102745T3 (hu) |
| EA (1) | EA003454B1 (hu) |
| EE (1) | EE04798B1 (hu) |
| ES (1) | ES2221417T3 (hu) |
| HK (1) | HK1039616B (hu) |
| HR (1) | HRP20010083B1 (hu) |
| HU (1) | HU227557B1 (hu) |
| IL (1) | IL141222A0 (hu) |
| IT (1) | IT1301993B1 (hu) |
| NO (1) | NO319773B1 (hu) |
| PL (1) | PL193828B1 (hu) |
| PT (1) | PT1102745E (hu) |
| RS (1) | RS49768B (hu) |
| SI (1) | SI1102745T1 (hu) |
| SK (1) | SK285527B6 (hu) |
| TR (1) | TR200100272T2 (hu) |
| UA (1) | UA65628C2 (hu) |
| WO (1) | WO2000007984A1 (hu) |
| ZA (1) | ZA200100907B (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2560502T3 (es) | 2005-07-01 | 2016-02-19 | Generics [Uk] Limited | Zofenopril calcio en forma de polimorfo C |
| EA012845B1 (ru) * | 2005-12-09 | 2009-12-30 | Менарини Интернэшнл Оперейшнс Люксембург С. А. | Фармацевтическая композиция, содержащая зофеноприл и hctz, для лечения гипертензии |
| DK2041083T3 (en) * | 2006-05-26 | 2015-01-26 | Generics Uk Ltd | Methods for the preparation of zofenopril calcium |
| GB0715626D0 (en) | 2007-08-10 | 2007-09-19 | Generics Uk Ltd | Crystalline form of zofenopril calcium |
| US8853421B2 (en) | 2008-02-27 | 2014-10-07 | Generics [Uk] Limited | Crystalline forms of zofenopril calcium |
| CN101981004B (zh) * | 2008-02-27 | 2014-09-17 | 基因里克斯(英国)有限公司 | 晶体形式 |
| EP2389360A4 (en) * | 2009-01-23 | 2013-01-16 | Glenmark Generics Ltd | METHOD FOR PRODUCING ZOFENOPRIL AND PHARMACEUTICAL ACCEPTIC SALTS THEREFOR |
| SI23949A (sl) | 2011-12-19 | 2013-06-28 | Silverstone Pharma | Nove kristalne soli zofenoprila, postopek za njihovo dobivanje in njihova uporaba v terapiji |
| CN104138359B (zh) * | 2013-05-06 | 2016-03-02 | 扬子江药业集团上海海尼药业有限公司 | 佐芬普利钙片的制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4105776A (en) * | 1976-06-21 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Proline derivatives and related compounds |
| US4154935A (en) * | 1978-02-21 | 1979-05-15 | E. R. Squibb & Sons, Inc. | Halogen substituted mercaptoacylamino acids |
| US4316906A (en) | 1978-08-11 | 1982-02-23 | E. R. Squibb & Sons, Inc. | Mercaptoacyl derivatives of substituted prolines |
-
1998
- 1998-08-04 IT IT1998MI001833A patent/IT1301993B1/it active IP Right Grant
-
1999
- 1999-07-30 CZ CZ20010408A patent/CZ301908B6/cs not_active IP Right Cessation
- 1999-07-30 RS YUP-75/01A patent/RS49768B/sr unknown
- 1999-07-30 EA EA200100095A patent/EA003454B1/ru not_active IP Right Cessation
- 1999-07-30 US US09/762,054 patent/US6521760B1/en not_active Expired - Fee Related
- 1999-07-30 SK SK163-2001A patent/SK285527B6/sk not_active IP Right Cessation
- 1999-07-30 HU HU0103826A patent/HU227557B1/hu unknown
- 1999-07-30 CN CNB998105171A patent/CN1146538C/zh not_active Expired - Lifetime
- 1999-07-30 BR BR9912842-0A patent/BR9912842A/pt not_active Application Discontinuation
- 1999-07-30 AU AU53722/99A patent/AU5372299A/en not_active Abandoned
- 1999-07-30 UA UA2001010590A patent/UA65628C2/uk unknown
- 1999-07-30 EP EP99939416A patent/EP1102745B1/en not_active Expired - Lifetime
- 1999-07-30 PT PT99939416T patent/PT1102745E/pt unknown
- 1999-07-30 ES ES99939416T patent/ES2221417T3/es not_active Expired - Lifetime
- 1999-07-30 KR KR1020017001379A patent/KR100593428B1/ko not_active IP Right Cessation
- 1999-07-30 WO PCT/EP1999/005461 patent/WO2000007984A1/en active IP Right Grant
- 1999-07-30 AT AT99939416T patent/ATE266635T1/de active
- 1999-07-30 EE EEP200100065A patent/EE04798B1/xx unknown
- 1999-07-30 CA CA002339283A patent/CA2339283C/en not_active Expired - Lifetime
- 1999-07-30 PL PL99345814A patent/PL193828B1/pl unknown
- 1999-07-30 SI SI9930575T patent/SI1102745T1/xx unknown
- 1999-07-30 TR TR2001/00272T patent/TR200100272T2/xx unknown
- 1999-07-30 DK DK99939416T patent/DK1102745T3/da active
- 1999-07-30 IL IL14122299A patent/IL141222A0/xx not_active IP Right Cessation
- 1999-07-30 JP JP2000563619A patent/JP2002522417A/ja active Pending
- 1999-07-30 DE DE69917282T patent/DE69917282T2/de not_active Expired - Lifetime
-
2001
- 2001-01-24 BG BG105176A patent/BG65022B1/bg unknown
- 2001-02-01 HR HR20010083A patent/HRP20010083B1/xx not_active IP Right Cessation
- 2001-02-01 CU CU20010032A patent/CU23171A3/es unknown
- 2001-02-01 NO NO20010552A patent/NO319773B1/no not_active IP Right Cessation
- 2001-02-01 ZA ZA200100907A patent/ZA200100907B/en unknown
-
2002
- 2002-02-21 HK HK02101248.6A patent/HK1039616B/zh not_active IP Right Cessation
- 2002-05-28 US US10/155,129 patent/US6515012B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0102556A3 (en) | Benzenesulfonamide-derivatives and their use as medicaments and process for the preparation of the compounds | |
| PL339449A1 (en) | Treatment of bone fractures involving the use of pthrp analogues | |
| HUP0103621A3 (en) | Fentanyl composition for the treatment of acute pain | |
| HK1011926A1 (en) | The use of bisphosphonates in bone surgery | |
| EP0711559A3 (en) | Use of phosphatidylserines for the manufacture of a medicament for improving brain activity | |
| IL119894A (en) | Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis | |
| ZA9610019B (en) | Process for the preparation of discrete particles of calcium carbonate | |
| ZA966985B (en) | A rapidly disintegrating medicinal form of tramadol or a tramadol salt. | |
| KR100213963B1 (en) | Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis | |
| IL145126A (en) | Process for the preparation of discrete particles of calcium carbonate | |
| HUP0103826A3 (en) | A process for the preparation of zofenopril calcium salt and medicament containing it and its use | |
| HU9600814D0 (en) | Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-1h-indole-5-ethanesulphonamide | |
| GB9303200D0 (en) | Orthopaedic casting bandage | |
| IL115223A0 (en) | Preparation containing antiresorptive compounds for use in the treatment of osteoporosis | |
| IL120005A0 (en) | Pharmaceutical compositions for the treatment of the eye | |
| EP0724842A3 (en) | Preparation for the treatment of obesity | |
| IL133739A (en) | Shaped products or structures for medical or related purposes | |
| HUP0103569A3 (en) | New medicament and process for its preparation | |
| IL123422A0 (en) | Use of 7alpha-methyl-17alpha-ethynyl-estrane derivatives for the manufacture of a medicament for the prophylaxis or the treatment of atherosclerosis | |
| KR100248098B1 (en) | Pharmaceutical composition for the treatment of dementia | |
| HUP0102868A3 (en) | Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain | |
| ME00862B (me) | Upotreba bisfosfonata za proizvodnju leka za inhibiranje resorpcije kostiju | |
| BG98206A (en) | Preparation for the treatment of morbid tumefactions of any origin | |
| GB9508012D0 (en) | Orthopaedic casts | |
| IL127227A0 (en) | A pharmaceutical composition for the treatment of multiple sclerosis |